Your browser doesn't support javascript.
loading
Blood Transfusion in the Age of Tranexamic Acid: Who Needs a Type and Screen Before Total Hip Arthroplasty?
Haider, Muhammad A; Ward, Spencer A; Rajahraman, Vinaya; Rozell, Joshua C; Macaulay, William; Schwarzkopf, Ran; Hepinstall, Matthew.
Affiliation
  • Haider MA; Department of Orthopedic Surgery, NYU Langone Health, New York, New York.
  • Ward SA; Department of Orthopedic Surgery, NYU Langone Health, New York, New York.
  • Rajahraman V; Department of Orthopedic Surgery, NYU Langone Health, New York, New York.
  • Rozell JC; Department of Orthopedic Surgery, NYU Langone Health, New York, New York.
  • Macaulay W; Department of Orthopedic Surgery, NYU Langone Health, New York, New York.
  • Schwarzkopf R; Department of Orthopedic Surgery, NYU Langone Health, New York, New York.
  • Hepinstall M; Department of Orthopedic Surgery, NYU Langone Health, New York, New York.
J Arthroplasty ; 2024 Jun 22.
Article in En | MEDLINE | ID: mdl-38914146
ABSTRACT

BACKGROUND:

Modern surgical protocols, particularly the use of tranexamic acid (TXA), have reduced, but not eliminated, blood transfusions surrounding total hip arthroplasty (THA). Identifying patients at risk for transfusion remains important for risk reduction and to determine type and screen testing.

METHODS:

We reviewed 6,405 patients who underwent primary, unilateral THA between January 2014 and January 2023 at a single academic institution, received TXA, and had preoperative hemoglobin (Hgb) values. We compared demographics, baseline Hgb levels, and surgical details between patients who were and were not transfused. Data were analyzed utilizing multivariate regression and receiver operating characteristic curve analysis.

RESULTS:

The overall perioperative and intraoperative transfusion rates were 3.4 and 1.0%, respectively. Patients who were older, women, and American Society of Anesthesiologists class >II demonstrated an increased risk of transfusion. Risk of transfusion demonstrated an inverse correlation with preoperative Hgb levels, a bimodal association with body mass index, and a direct correlation with age, surgical time, and estimated blood loss on multivariate analysis. The receiver operating characteristic analysis demonstrated a preoperative Hgb cutoff of 12 g/dL for predicting any transfusion. Above the threshold of 12 g/dL, total and intraoperative transfusions were rare, with rates of 1.7 and 0.3%, respectively. Total and intraoperative transfusion rates with Hgb between 11 and 12 g/dL were 14.3 and 4.6%, respectively. Below 11 g/dL, total and intraoperative transfusion rates were 27.5 and 10.1%, respectively.

CONCLUSIONS:

In the age of TXA, blood transfusion is rare in THA when preoperative Hgb is >12 g/dL, challenging the need for universal type and screening. Conversely, patients who have Hgb < 11.0 g/dL, remain at substantial risk for transfusion. Between Hgb 11 and 12 g/dL, patient age, sex, body mass index, American Society of Anesthesiologists classification, anticipated estimated blood loss, and surgical time may help predict transfusion risk and the need for a perioperative type and screen. LEVEL OF EVIDENCE III.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Arthroplasty Journal subject: ORTOPEDIA Year: 2024 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Arthroplasty Journal subject: ORTOPEDIA Year: 2024 Document type: Article Country of publication: United States